CRISPR Therapeutics AG (CRSP)
56.26
-3.34
(-5.60%)
USD |
NASDAQ |
Jun 21, 16:00
56.27
+0.01
(+0.02%)
After-Hours: 20:00
CRISPR Therapeutics Gross Profit (Quarterly): -46.97M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -46.97M |
December 31, 2023 | 180.00M |
September 30, 2023 | -23.42M |
June 30, 2023 | 25.36M |
March 31, 2023 | 57.81M |
December 31, 2022 | -6.817M |
September 30, 2022 | -38.76M |
Date | Value |
---|---|
June 30, 2022 | -33.76M |
March 31, 2022 | -30.47M |
December 31, 2021 | -19.48M |
September 30, 2021 | -22.14M |
June 30, 2021 | 873.26M |
March 31, 2021 | -19.74M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
-46.97M
Minimum
Mar 2024
873.26M
Maximum
Jun 2021
68.84M
Average
-19.74M
Median
Mar 2021
Gross Profit (Quarterly) Benchmarks
Vertex Pharmaceuticals Inc | 2.348B |
Intellia Therapeutics Inc | -- |
Novartis AG | 9.024B |
MoonLake Immunotherapeutics | -- |
Regeneron Pharmaceuticals Inc | 2.711B |